Search for: "IN RE JOHNSON & JOHNSON DERIVATIVE LITIGATION" Results 1 - 20 of 123
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 Sep 2012, 5:40 am by Ted Frank
The Center for Class Action Fairness is putting that question to the test in In re Johnson & Johnson Shareholder Derivative Litigation by asking the District of New... [read post]
23 May 2024, 10:28 am by Peter S. Lubin and Patrick Austermuehle
However, this fiduciary duty is only recognized when a partner derives profits without the consent of the other partners (Johnson v. [read post]
8 Nov 2011, 5:00 am by J Robert Brown Jr.
  A recent case that looked to New Jersey law but in actuality applied Delaware law, see In re Johnson & Johnson Derivative Litigation, 2011 US Dist. [read post]
16 Aug 2016, 12:10 pm by Michael Grossman
Almost regardless of what we’re doing, we perspire. [read post]
7 May 2024, 1:23 pm by Adam Levitin
Johnson & Johnson is preparing to take a third crack at addressing its toxic talc liabilities through bankruptcy in what we might call a "Texas Three-Step". [read post]
2 May 2009, 10:12 am
OpinionsSUPREME COURT MANDAMUS ENDS SHAREHOLDER DERIVATIVE SUITIn Re Schmitz, (Tex. 2009)No. 07-0581 (Tex. [read post]
24 Jun 2019, 5:02 pm by Lundgren & Johnson, PSC
  At Lundgren & Johnson, we believe that a proper explanation is more important than just giving the correct answer. [read post]
24 Jun 2019, 5:02 pm by Lundgren & Johnson, PSC
  At Lundgren & Johnson, we believe that a proper explanation is more important than just giving the correct answer. [read post]
13 Aug 2011, 8:57 am by Rebecca Tushnet
Johnson, University of North Dakota School of Law, Intellectual Property and the Incentive Fallacy IP is nonexcludable and nonrival. [read post]
8 Jan 2009, 9:35 am
He thinks Prince "almost certainly" will win: "Prince's process means his paintings will almost certainly be declared transformative, not derivative works, and as such, they're fair use, not infringing. [read post]
2 Sep 2009, 11:22 pm
Johnson & Johnson, L.P., 2009 WL 2252198, at *3-4 (D. [read post]
29 Aug 2016, 1:19 pm by Michael Grossman
While patients have several complaints about the drug, the current multi-district litigation (MDL) directed at Johnson & Johnson focuses mainly on one very uncomfortable side effect of Risperdal and/or Invega use. [read post]
5 Aug 2008, 10:24 am
(You gotta love the bizarro world of derivative-suit litigation!) [read post]